{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:41:33Z","timestamp":1784014893866,"version":"3.55.0"},"reference-count":57,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FT220100186"],"award-info":[{"award-number":["FT220100186"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Issues<\/jats:title><jats:p>Project Stop, a real\u2010time monitoring program for pseudoephedrine\u2010containing medicines, was initiated in 2005 by the Pharmacy Guild of Australia in collaboration with police in the state of Queensland. The program implemented an online database to record pseudoephedrine purchases (and attempted purchases) to prevent large\u2010scale diversion to methamphetamine production.<\/jats:p><\/jats:sec><jats:sec><jats:title>Approach<\/jats:title><jats:p>This narrative review aims to understand the overall impact of Project Stop, what evidence exists for this kind of intervention in Australia, and what lessons can be learned from its introduction. Systematic database searches were conducted in Embase, PubMed, Web of Science and Google Scholar, with 20 relevant sources selected for inclusion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Findings<\/jats:title><jats:p>Project Stop successfully prevented some pseudoephedrine from being diverted from pharmacies to methamphetamine production. The intervention has been most effective in jurisdictions that made the program mandatory. Project Stop was also associated with a temporary decline in clandestine laboratory seizures in Queensland, changes in methamphetamine production methods and reduced voluntary treatment admissions for methamphetamine use. Implementation was not associated with an appreciable effect on secondary indicators, such as methamphetamine production and harmful use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Implications<\/jats:title><jats:p>Future applications of a Project Stop model must ensure ongoing impact evaluation, assessment of its effect on individual's drug\u2010related behaviour and combine it with policies that address drug use as a health issue.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Project Stop has been narrowly successful in terms of reducing pseudoephedrine diversion and demonstrates the potential for third\u2010party policing practices directed at the consumer level, in collaboration with healthcare practitioners, rather than only regulating precursor wholesalers.<\/jats:p><\/jats:sec>","DOI":"10.1111\/dar.13777","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T23:52:45Z","timestamp":1700005965000},"page":"325-342","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The impact of pseudoephedrine regulation at <scp>Australian<\/scp> pharmacies through <scp>Project Stop<\/scp>: A narrative review"],"prefix":"10.1111","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2199-1109","authenticated-orcid":false,"given":"Samuel","family":"Brookfield","sequence":"first","affiliation":[{"name":"School of Public Health The University of Queensland  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6651-8035","authenticated-orcid":false,"given":"Coral","family":"Gartner","sequence":"additional","affiliation":[{"name":"School of Public Health The University of Queensland  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32230-5"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/1057567717730104"},{"key":"e_1_2_10_4_1","unstructured":"Australian institute of Health and welfare.National Drug Strategy Household Survey 2019. Canberra.2020."},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/0022042617751685"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/10439460600973693"},{"key":"e_1_2_10_7_1","volume-title":"Third party policing","author":"Mazerolle L","year":"2005"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00539.x"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00450.x"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2007.12.006"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.04.011"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/0887403409352209"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/002204261104100206"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.10.001"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjc\/azr005"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpubeco.2014.07.011"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17217840"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrimjus.2021.101795"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/1745-9125.12200"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6433a4"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03582.x"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02099.x"},{"key":"e_1_2_10_23_1","unstructured":"RansleyJ MazerolleL ManningM McguffogI DrewJM WebsterJL.Reducing the methamphetamine problem in Australia: evaluating innovative partnerships between police pharmacies and other third parties. NDLERF.2011."},{"key":"e_1_2_10_24_1","unstructured":"Parliamentary Joint Committee of the Australian Crime Commission.Inquiry into the manufacture importation and use of amphetamines and other synthetic drugs (AOSD) in Australia.2007."},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1211\/ijpp.17.04.0003"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0143814X13000147"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2013.02.003"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijpp.12153"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/10439463.2013.817994"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-016-0075-0"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2016.03.012"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13648"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/10439463.2016.1272602"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/1098611111404017"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2009.00051.x"},{"key":"e_1_2_10_36_1","unstructured":"Crime and Misconduct Commission.Illicit drug markets in Queensland: A strategic assessment.2010."},{"key":"e_1_2_10_37_1","unstructured":"RitterA BrightD GongW.Evaluating drug law enforcement interventions directed towards methamphetamine in Australia.2012."},{"key":"e_1_2_10_38_1","doi-asserted-by":"crossref","unstructured":"FerrisJ DevaneyM MazerolleL Sparkes\u2010CarrollM.Assessing the utility of Project STOP in reducing pseudoephedrine diversion to clandestine laboratories. Australian Institute of Criminology.2016.","DOI":"10.52922\/ti235944"},{"key":"e_1_2_10_39_1","unstructured":"Pharmacy Guild of Australia.Submission to the Parliamentary Joint Committee on the Australian Crime Commission Inquiry into Amphetamines and Other Synthetic Drugs (AOSD).2006."},{"key":"e_1_2_10_40_1","unstructured":"GluckmanP.Consideration of reduction of access to or elimination of pseudoephedrine in \u2018cold and flu\u2019 preparations: Report to the Prime Minister.2009."},{"key":"e_1_2_10_41_1","unstructured":"Australian Crime Commission.Submission to Select Committee of the Legislative Assembly of the Northern Territory Inquiry into methylamphetamine.2015."},{"key":"e_1_2_10_42_1","unstructured":"McGuffogI.Drug use and drug control policy: evaluating the impact of precursor regulation on drug user behaviour: Griffith University.2012."},{"key":"e_1_2_10_43_1","first-page":"3","article-title":"Pseudo alert for pharmacy","volume":"91","author":"Gupte J","year":"2010","journal-title":"Aust J Pharm"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13468"},{"key":"e_1_2_10_45_1","unstructured":"Queensland Health.Queensland Health methamphetamine paper.2017."},{"key":"e_1_2_10_46_1","unstructured":"CoyneJ WhiteV AlvarezC.Methamphetamine: focusing Australia's National ice Strategy on the problem not the symptoms. Australian Strategic Policy Institute.2015."},{"key":"e_1_2_10_47_1","unstructured":"Commonwealth of Australia.National Ice Action Strategy 2015.2015."},{"key":"e_1_2_10_48_1","unstructured":"Department of Health.National Ice Action Strategy Rollout.2019."},{"key":"e_1_2_10_49_1","unstructured":"Department of Health.National Drug Strategy 2017\u20132026.2017."},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13205"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/07418825.2019.1675746"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1080\/0735648X.2008.9721255"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103427"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/0033294118764918"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02234.x"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091450920905372"},{"key":"e_1_2_10_57_1","unstructured":"Parliamentary Joint Committee on Law Enforcement.Inquiry into crystal methamphetamine (ice). Final report.2018."},{"key":"e_1_2_10_58_1","unstructured":"Parliamentary Joint Committee on Law Enforcement.Hansard Transcript: Wednesday 12 August 2015.2015."}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T11:48:44Z","timestamp":1706701724000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.13777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,14]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1111\/dar.13777"],"URL":"https:\/\/doi.org\/10.1111\/dar.13777","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,14]]},"assertion":[{"value":"2023-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}